Dihydroartemisinin overcomes cisplatin resistance in bladder cancer via suppression of the PI3K/AKT/ABCB1 signaling Axis
Scientific Reports, Published online: 24 September 2026; doi:10.1038/s41598-026-72256-w Dihydroartemisinin overcomes cisplatin resistance in bladder cancer via suppression of the PI3K/AKT/ABCB1 signaling Axis
We haven't written up this one. Scientific Reports has the full story — the link below goes straight to it.